Contraception
RSSArticles
-
Pill still is popular family planning option
-
More women moving to intrauterine device use
-
Thumbs down to Pill’s over-the-counter access
-
Phenotypic Differences between Male Physicians, Surgeons, and Film Stars: Comparative Study
The investigators enticed 14 male surgeons and 16 male physicians (internal medicine and sub-specialists) to submit recent photographs of themselves to the investigators and to indicate how tall they were. -
Pharmacology Watch: Breast Cancer Rates Have Dropped Since WHI of 2002
Herbal Supplements to Treat Vasomotor Symptoms; Bisphosphonates to Treat LBD, After 5 Years?; FDA Actions -
Decline in Breast Cancer and Reduced Use of Hormone Therapy
Ravdin and colleagues from the University of Texas M.D. Anderson Cancer Center reported a 7% decrease (14,000 fewer cases) in the incidence of breast cancer in 9 regions of the U.S. in 2003. -
Breast Cancer Risk in Finnish Women Using Estrogen-Only Therapy
Lyytinen and colleagues from Helsinki reported the results of a cohort study assessing the risk of breast cancer in postmenopausal Finnish women using oral, transdermal, and vaginal estrogen products containing either estradiol or estriol. -
Clinical Briefs in Primary Care supplement
-
Post-Menopausal Hormone Therapy and Ovarian Cancer Risk
Lacey and colleagues from the National Cancer Institute reported the results of postmenopausal hormone exposure in a cohort study with 214 cases of ovarian cancer.1 The over-all cohort of 97,368 women constituted the NIH-AARP Diet and Health Study. -
Pharmacology Watch: Study: Long-Term Use of Clopidogrel for DES Patients
Drug Labels A Prescription for Misunderstanding?; Osteonecrosis of the Jaw New Side-Effect to Bisphosphate Use; Beta-Blockers and Depression Unlinked?; FDA Actions